Search Results - "Won, Haejung"
-
1
TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
Published in Clinical cancer research (15-08-2015)“…Recent advances in immunotherapy of advanced human cancers underscored the need to address and eliminate tumor immune evasion. The myeloid-derived suppressor…”
Get full text
Journal Article -
2
TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs
Published in Journal of leukocyte biology (01-08-2017)“…TLR9 upregulation in prostate cancer cells results in the LIF‐mediated recruitment and increased tolerogenic activity of polymorphonuclear myeloid‐derived…”
Get full text
Journal Article -
3
Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy
Published in International journal of molecular sciences (13-04-2019)“…Currently, there are two Food and Drug Administration (FDA)-approved drugs for androgen deprivation therapy (ADT) of metastatic castration-resistant prostate…”
Get full text
Journal Article -
4
Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity
Published in The Journal of clinical investigation (19-01-2021)“…The tumor microenvironment affects the outcome of radiotherapy against head and neck squamous cell carcinoma (HNSCC). We recently found that tolerogenic…”
Get full text
Journal Article -
5
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
Published in Blood (31-03-2016)“…Targeting oncogenic transcription factor signal transducer and activator of transcription 3 (STAT3) in acute myeloid leukemia (AML) can reduce blast survival…”
Get full text
Journal Article -
6
Abstract 35: Chemo-radiotherapy induces tolerogenic STAT3 signaling in circulating myeloid-derived suppressor cells in patients with head and neck squamous cell carcinoma (HNSCC)
Published in Clinical cancer research (01-12-2017)“…Abstract Background and Objectives: While radiation therapy (RT) and certain types of chemotherapy are potentially immunogenic, they rarely generate antitumor…”
Get full text
Journal Article -
7
Effect of IL-6 and related mediators on resistance to abiraterone acetate (abi) and enzalutamide (enza) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Published in Journal of clinical oncology (01-03-2019)“…Abstract only 296 Background: IL-6 is an upstream regulator of various moieties, including STAT3, that are associated with a poor prognosis in mCRPC. The…”
Get full text
Journal Article -
8
Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1
Published in Blood (23-10-2014)“…The mechanisms controlling the development of dendritic cells (DCs) remain incompletely understood. Using an Mysm1 knockout (Mysm1−/−) mouse model, we…”
Get full text
Journal Article -
9
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients
Published in Oncotarget (16-02-2018)“…Immunomodulation contributes to the antitumor efficacy of the fractionated radiation therapy (RT). Here, we describe immune effects of RT with concurrent…”
Get full text
Journal Article -
10
B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
Published in Molecular therapy (07-03-2018)“…Growing evidence links the aggressiveness of non-Hodgkin’s lymphoma, especially the activated B cell-like type diffuse large B cell lymphomas (ABC-DLBCLs) to…”
Get full text
Journal Article -
11
Association of microbiome and plasma cytokine dynamics to nivolumab response in metastatic renal cell carcinoma (mRCC)
Published in Journal of clinical oncology (20-02-2018)“…Abstract only 656 Background: Checkpoint inhibitors (CPI) represent a standard of care in mRCC. The relationship of the microbiome to benefit from CPIs has…”
Get full text
Journal Article -
12
261. Gain-of-Function Effect Augments Therapeutic Efficacy of CpG-STAT3 Anti-Sense Oligonucleotide Against Castration-Resistant Prostate Cancers
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
13
Control of B Cell Development by the Histone H2A Deubiquitinase MYSM1
Published in Immunity (Cambridge, Mass.) (23-12-2011)“…Epigenetic histone modifications play critical roles in the control of gene transcription. Recently, an increasing number of histone H2A deubiquitinases have…”
Get full text
Journal Article -
14
Gut microbiome composition and response to sunitinib in metastatic renal cell carcinoma (mRCC)
Published in Journal of clinical oncology (20-02-2018)“…Abstract only 657 Background: Recent evidence supports a link between stool microbiome composition and immunotherapy response. However, it is unclear how the…”
Get full text
Journal Article -
15
Histone H2A deubiquitinase MYSM1 is essential for dendritic cell development (P4488)
Published in The Journal of immunology (1950) (01-05-2013)“…Abstract The mechanisms controlling differentiation of dendritic cells remain largely unknown. Using knockout mouse model, we identified Mysm1 as a critical…”
Get full text
Journal Article